innerpink Feminine Spot

Manufacturer
GuStar Co., Ltd. | Kolmar Korea Co.,LTD. Gwanjeong Factory
Effective date
2023-04-19
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:54:44

Label at a glance#

Productinnerpink Feminine Spot
Active ingredientNiacinamide, Adenosine
Label structure10 sections

Dosage and administration

■ After taking a shower, apply an appropriate amount. ■ Gently spread on the skin. ■ Can be used in any skin area for immediate calming effect of troubled skin.

Label contents#

Full prescribing information#

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 2.0%
Adenosine 0.04%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

WATER, GLYCERIN, ETHYLHEXYL STEARATE, METHYLPROPANEDIOL, POLYGLYCERYL-3 DISTEARATE, CETEARYL ALCOHOL, 1,2-HEXANEDIOL, BUTYROSPERMUM PARKII (SHEA) BUTTER, CYCLODEXTRIN, METHYL TRIMETHICONE, DIPROPYLENE GLYCOL, PALMITIC ACID, BEHENYL ALCOHOL, GLYCERYL STEARATE SE, STEARIC ACID, TROMETHAMINE, LECITHIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, SODIUM STEAROYL GLUTAMATE, ETHYLHEXYLGLYCERIN, MELIA AZADIRACHTA FLOWER EXTRACT, HYDROGENATED LECITHIN, LAMINARIA JAPONICA EXTRACT, ECLIPTA PROSTRATA LEAF EXTRACT, DISODIUM EDTA, MELIA AZADIRACHTA LEAF EXTRACT, CURCUMA LONGA (TURMERIC) ROOT EXTRACT, OCIMUM SANCTUM LEAF EXTRACT, FICUS CARICA (FIG) FRUIT EXTRACT, CENTELLA ASIATICA EXTRACT,FRUCTOOLIGOSACCHARIDES, TOCOPHEROL, MYRISTIC ACID, BETA-GLUCAN, QUERCETIN, CORALLINA OFFICINALIS EXTRACT, CINNAMOMUM ZEYLANICUM BARK OIL, CHOLESTEROL, CERAMIDE NP, RESVERATROL, GINSENOSIDES, ULMUS DAVIDIANA ROOT EXTRACT, AMARANTHUS CAUDATUS SEED EXTRACT, EUGENIA CARYOPHYLLUS (CLOVE) BUD OIL, HYDROLYZED HYALURONIC ACID, LACTOBACILLUS FERMENT, ETHYL HEXANEDIOL, HYDROLYZED COLLAGEN, CURCUMIN, LACTOBACILLUS FERMENT LYSATE, LACTOCOCCUS FERMENT LYSATE, LACTOBACILLUS/PUNICA GRANATUM FRUIT FERMENT EXTRACT, LACTOBACILLUS/ACEROLA CHERRY FERMENT, LACTOBACILLUS/SOYBEAN FERMENT EXTRACT, LACTOCOCCUS FERMENT, LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE, BIFIDA FERMENT FILTRATE, SODIUM HYALURONATE, STREPTOCOCCUS THERMOPHILUS FERMENT, BIFIDA FERMENT LYSATE, SODIUM ACETYLATED HYALURONATE

PURPOSE

OTC - PURPOSE SECTION

Skin Brightening
Anti wrinkle

WARNINGS

WARNINGS SECTION

For external use only
1. In case of using cosmetics or after use, please consult a specialist if there is any abnormal symptom or side effect such as red spot, swelling or itching in direct sunlight.
2. Do not use on wounded areas.
3. Precautions for storage and handling
a) Keep out of reach of children.
b) Avoid direct sunlight.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Use(s)

INDICATIONS & USAGE SECTION

■ Dual functional: Dark skin brightening and Anti-wrinkle
■ Immediately smoothes troubled skin
■ Block unpleasant Odor
■ Quick hydration with hyaluronic acid
■ Increase beneficial bacteria

Directions

DOSAGE & ADMINISTRATION SECTION

■ After taking a shower, apply an appropriate amount.
■ Gently spread on the skin.
■ Can be used in any skin area for immediate calming effect of troubled skin.

Other Information

OTHER SAFETY INFORMATION

■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73819-0015-22024-07-30C16284748780-11030e364-febc-111a-e063-dadaa90a10e2Drug Facts
73819-0015-22024-01-30C16284748780-11030e364-febc-111a-e063-dadaa90a10e2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73819-0015-1innerpink Feminine Spot50 g in 1 CONTAINERCREAM501
73819-0015-2innerpink Feminine Spot1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73819-0015INNERPINK FEMININE SPOT (NIACINAMIDE, ADENOSINE) CREAM [GUSTAR CO., LTD.]12 package rows20230420_e4b68416-3302-4797-a07f-ef10c498c986.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73819-001573819-0015-1, 73819-0015-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
140d8384-fab6-48cf-9c86-ebb7f2b8e2a0e4b68416-3302-4797-a07f-ef10c498c9862023-04-19WarningsExact identifier
spl id: 140d8384-fab6-48cf-9c86-ebb7f2b8e2a0
spl set id: e4b68416-3302-4797-a07f-ef10c498c986

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.